Cohort entry was defined as the date of the first-ever prescription for one of the drugs of interest (GLP-1RAs, SGLT2 inhibitors, metformin or other second- or third-line glucose-lowering drugs) during the study period, and their respective first exposure was defined as the index event
Featured Products Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, mimics the activity of mammalian incretin hormone glucagon-like peptide 1 (GLP-1), and thus, promotes insulin secretion and functions in the control of glucose [1]
Treatment may involve supportive care, such as rest, intravenous fluids, and medications to control vomiting
Avoid freezing/thawing cycles and exposure to light
Myakala, K
For those who decide to try Integrative Peptides, starting with the delayed release BPC-157 Pure capsules makes sense for most applications